BrainChip (BRN) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
20 Nov, 2025Opening remarks and agenda
Acknowledgement of traditional custodians and welcome to attendees, both in-person and virtual.
Introduction of board members, executive team, and auditors; confirmation of quorum and meeting procedures.
Explanation of voting and Q&A logistics for both in-person and online participants.
Financial performance review
Discussion of revenue recognition rules, bookings versus revenue, and the importance of long-term projections.
Target bookings for the year set at $9 million, with CEO compensation tied to this metric.
Company not yet cash flow neutral, but aims to achieve this within the next one to two years.
Shareholders expressed concerns over share price decline, dilution, and lack of major commercial license agreements.
Board and executive committee updates
Board composition reviewed, with re-election of directors and introduction of a self-nominated candidate.
Non-executive directors deferred annual grants to 2026 as a sign of solidarity and confidence.
CEO and executive compensation now more closely tied to performance and bookings.
Latest events from BrainChip
- Revenue up 374%, net loss reduced, and $37M raised to accelerate neuromorphic AI growth.BRN
H2 202526 Feb 2026 - Revenue up 72% and net loss reduced, with strong capital raises and key commercial wins.BRN
H2 202420 Feb 2026 - Cash position strengthened and new partnerships drive momentum for neuromorphic AI products.BRN
Q4 202529 Jan 2026 - Cash balance rose to $13.9M as AKD1500 enters volume production, backed by new capital and partnerships.BRN
Q3 20251 Dec 2025 - $35M placement and $2M SPP to accelerate edge AI commercialization and product expansion.BRN
Investor Presentation10 Nov 2025 - Edge AI and neuromorphic solutions drive growth across defense, healthcare, and consumer markets.BRN
Investor Presentation19 Oct 2025 - Revenue soared 859% and net loss narrowed, with new funding and partnerships fueling growth.BRN
H1 202521 Aug 2025 - Customer receipts surged and cash burn improved, supporting ongoing growth and innovation.BRN
Q2 202529 Jul 2025 - Cash position strengthened to US$25.6M, supporting commercialization and product development.BRN
Q3 202413 Jun 2025